BioNTech Investor Presentation Deck
2022: Success Through Further Development of the COVID-19 Vaccine
18
2022: Strong market position
>3.6 bn doses shipped to 180 countries and regions
since product launch¹
• Order book 20221: -2.5 bn doses
As of beginning of July 2022
Distribution of COVID-10 vaccine in collaboration with Pfizer
Expansion of global market position
✓Pediatric label expansion for different age groups
Evaluation and approval of booster
✓Label expansion to additional at-risk groups
✓ Future pandemic preparedness
Monitoring of emerging variants
Rapid data-guided vaccine adaptation
●
●
✓ Development of variant-adapted and next-
generation vaccines.
• Plan to launch Omicron-adapted vaccine in fall
2022
●
Multipronged next-generation vaccine strategy
designing and testing multiple constructs.
BIONTECHView entire presentation